Calreticulin exposure dictates the immunogenicity of cancer cell death
about
Oncolytic viruses as therapeutic cancer vaccinesGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Phosphatidylserine targets single-walled carbon nanotubes to professional phagocytes in vitro and in vivoRegulation of autophagy by the inositol trisphosphate receptorFunctional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 proteinThrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikisStructural framework of the GABARAP-calreticulin interface--implications for substrate binding to endoplasmic reticulum chaperonesA physical interaction network of dengue virus and human proteinsCalreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47Perspectives on anti-CD47 antibody treatment for experimental cancerAnti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell responseThe CD47-SIRPĪ± pathway in cancer immune evasion and potential therapeutic implicationsExpression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancerMacrophages discriminate glycosylation patterns of apoptotic cell-derived microparticlesA novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell deathThe CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsClassification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009Adoptive T cell therapy for cancer in the clinicRadiotherapy combination opportunities leveraging immunity for the next oncology practiceNecroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapyIs the Antitumor Property of Trypanosoma cruzi Infection Mediated by Its Calreticulin?Dendritic-Tumor Fusion Cell-Based Cancer VaccinesAdvances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancerKey mechanisms governing resolution of lung inflammationInvolvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based ImmunotherapyExercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and ProgressionExploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer ImmunotherapyRadio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical ApplicationsA sequence-specific DNA binding small molecule triggers the release of immunogenic signals and phagocytosis in a model of B-cell lymphomaConcepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapiesModulation of APC Function and Anti-Tumor Immunity by Anti-Cancer DrugsWhole Tumor Antigen Vaccines: Where Are We?Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in CancerImmune Modulation in Hematologic MalignanciesExtracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current DogmaThe Concept of Hormesis in Cancer Therapy - Is Less More?Endoplasmic reticulum chaperones and oxidoreductases: critical regulators of tumor cell survival and immunorecognitionApoptotic cell clearance: basic biology and therapeutic potential.An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas
P2860
Q21245758-D71E1797-167E-4F6A-85F3-078AFF3A4AA1Q22676705-C8CF5A39-6FFF-4E20-94A6-DB78C6B61B8EQ23918711-AA2D9747-C7F2-4FC4-9FC9-549D2F2DAAFBQ24294716-3EA41F98-2497-4D04-97DF-E3F3A0A06CC1Q24303558-D05C97C0-F440-4CC3-8BD0-4E4C8B36A75EQ24314282-32A294F2-BC55-4A17-A7F7-DBFA04913EC0Q24316639-F70EA96B-3A56-4098-BD60-AC629BF75355Q24318542-C4DB078E-E771-466A-907F-C8999844A9CBQ24337769-8A5AFBD4-5014-4C8F-A6EC-91BB935EBE09Q24561405-3F97A135-D113-418E-9F07-77E72EDC6FC6Q24602779-9D20ADCA-EAAA-4EB2-8BD6-133C34B18A82Q24602822-06DCB4BB-333A-4B48-A764-6C7BC5A6D29CQ24605052-22B6C192-C2BD-49E0-B931-DBD1ED2E613FQ24609433-16897C64-0066-4F66-B97B-0944C6402E78Q24616421-40879C33-06F2-42A7-ACFF-4D95AE91FCC5Q24620548-6F17449F-D5FD-46D6-B471-DF17D9C7E679Q24631515-6EE4D6A7-13B7-4444-B79E-0C37E67EA97FQ24653924-8CA5A526-5517-44FD-A235-4DEA0375CAC3Q24680405-A67C20D4-50BD-4CA8-B99C-A9CF458A275CQ26738443-7ACC3D86-144F-4102-90B0-4A1891652254Q26739959-9462D45D-FF28-45B9-871C-3EB1DD598956Q26741412-4C2124C3-8F76-4614-9225-748D911E98D8Q26744827-5C0E5F9A-A399-4872-854E-639DF3DA1AB9Q26749451-45F601DE-C578-4E18-9569-64C84E2ADD60Q26749606-F4F935E1-B210-4FAB-A81B-EFA8F89F45C0Q26765594-D4E1A23E-36BF-423D-A463-05B79BA7528CQ26775189-2F72E168-26C5-4ED5-88EC-AE7170AA3834Q26779184-6422A98F-4F2F-46D3-99E6-60EE600692DDQ26779221-6D5D2853-D195-472A-9D36-1D2070EB24ACQ26780141-A93EAB0E-E871-4DD9-B592-67482299A031Q26781215-1F8EF7E7-62C1-405D-9129-7BB59AA2932DQ26781522-80869AA6-BA48-4EBC-9D83-6A455AE6CE1EQ26783866-49D9EF6F-B5CF-4E99-87AB-D6A2D483066EQ26795466-EF33ECE6-AB6D-4BE7-802C-017C33300C14Q26796307-B67129EB-110E-415D-8774-A6F93C34A54DQ26798468-A95BEED8-4953-4127-80B5-FA43D8ACA8C4Q26800519-749E1C6B-4029-411C-889A-97367B7E00BAQ26823628-939613EA-FB0A-487A-8FFC-DF7D54BB85EBQ26825935-ABE16E1A-E3C9-4CB7-9FE5-4B018E8926D6Q26852232-FF4996A0-F6A2-46FF-91C6-B364379429FD
P2860
Calreticulin exposure dictates the immunogenicity of cancer cell death
description
2007 nĆ® lÅ«n-bĆ»n
@nan
2007 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« Õ
ÕøÖÕ¶ÕøÖÕ”ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2007 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ°ÕøÖÕ¶Õ¾Õ”ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2007幓ć®č«ę
@ja
2007幓č«ę
@yue
2007幓č«ę
@zh-hant
2007幓č«ę
@zh-hk
2007幓č«ę
@zh-mo
2007幓č«ę
@zh-tw
2007幓č®ŗę
@wuu
name
Calreticulin exposure dictates the immunogenicity of cancer cell death
@ast
Calreticulin exposure dictates the immunogenicity of cancer cell death
@en
Calreticulin exposure dictates the immunogenicity of cancer cell death
@nl
type
label
Calreticulin exposure dictates the immunogenicity of cancer cell death
@ast
Calreticulin exposure dictates the immunogenicity of cancer cell death
@en
Calreticulin exposure dictates the immunogenicity of cancer cell death
@nl
prefLabel
Calreticulin exposure dictates the immunogenicity of cancer cell death
@ast
Calreticulin exposure dictates the immunogenicity of cancer cell death
@en
Calreticulin exposure dictates the immunogenicity of cancer cell death
@nl
P2093
P50
P3181
P356
P1433
P1476
Calreticulin exposure dictates the immunogenicity of cancer cell death
@en
P2093
Didier MĆ©tivier
Maria Castedo
Michel Obeid
Noelia Casares
Theoharis Panaretakis
P2888
P3181
P356
10.1038/NM1523
P407
P50
P577
2007-01-01T00:00:00Z